BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23235486)

  • 21. Pd-catalyzed asymmetric allylic etherification using chiral biphenol-based diphosphinite ligands and its application for the formal total synthesis of (-)-galanthamine.
    Zang Y; Ojima I
    J Org Chem; 2013 Apr; 78(8):4013-8. PubMed ID: 23472673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SpinPhox/iridium(I)-catalyzed asymmetric hydrogenation of cyclic α-alkylidene carbonyl compounds.
    Liu X; Han Z; Wang Z; Ding K
    Angew Chem Int Ed Engl; 2014 Feb; 53(7):1978-82. PubMed ID: 24446418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chiral 1-phenylethylamine-derived phosphine-phosphoramidite ligands for highly enantioselective Rh-catalyzed hydrogenation of beta-(acylamino)acrylates: significant effect of substituents on 3,3'-positions of binaphthyl moiety.
    Zhou XM; Huang JD; Luo LB; Zhang CL; Hu XP; Zheng Z
    Org Biomol Chem; 2010 May; 8(10):2320-2. PubMed ID: 20376384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An approach to bimetallic catalysts by ligand design.
    López-Valbuena JM; Escudero-Adan EC; Benet-Buchholz J; Freixa Z; van Leeuwen PW
    Dalton Trans; 2010 Sep; 39(36):8560-74. PubMed ID: 20697645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical optimization of artificial metalloenzymes based on the biotin-avidin technology: (S)-selective and solvent-tolerant hydrogenation catalysts via the introduction of chiral amino acid spacers.
    Skander M; Malan C; Ivanova A; Ward TR
    Chem Commun (Camb); 2005 Oct; (38):4815-7. PubMed ID: 16193124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoenzymatic synthesis of a mixed phosphine-phosphine oxide catalyst and its application to asymmetric allylation of aldehydes and hydrogenation of alkenes.
    Boyd DR; Bell M; Dunne KS; Kelly B; Stevenson PJ; Malone JF; Allen CC
    Org Biomol Chem; 2012 Feb; 10(7):1388-95. PubMed ID: 22218455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Captured at last: a catalyst-substrate adduct and a Rh-dihydride solvate in the asymmetric hydrogenation by a Rh-monophosphine catalyst.
    Gridnev ID; Alberico E; Gladiali S
    Chem Commun (Camb); 2012 Feb; 48(16):2186-8. PubMed ID: 22251950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of ligand variation on enantioselective hydrogenation catalysed by RuH2(diphosphine)(diamine) complexes.
    Chen HY; Di Tommaso D; Hogarth G; Catlow CR
    Dalton Trans; 2012 Feb; 41(6):1867-77. PubMed ID: 22166917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pd-catalyzed asymmetric allylic amination of Morita-Baylis-Hillman adduct derivatives using chiral diaminophosphine oxides: DIAPHOXs.
    Nemoto T; Fukuyama T; Yamamoto E; Tamura S; Fukuda T; Matsumoto T; Akimoto Y; Hamada Y
    Org Lett; 2007 Mar; 9(5):927-30. PubMed ID: 17284046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High asymmetric induction with beta-turn-derived palladium phosphine complexes.
    Greenfield SJ; Agarkov A; Gilbertson SR
    Org Lett; 2003 Aug; 5(17):3069-72. PubMed ID: 12916983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial metalloenzymes based on the biotin-avidin technology: enantioselective catalysis and beyond.
    Ward TR
    Acc Chem Res; 2011 Jan; 44(1):47-57. PubMed ID: 20949947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhodium phosphine-phosphite catalysts in the hydrogenation of challenging N-(3,4-dihydronaphthalen-2-yl) amide derivatives.
    Arribas I; Rubio M; Kleman P; Pizzano A
    J Org Chem; 2013 Apr; 78(8):3997-4005. PubMed ID: 23485121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly enantioselective hydrogenation of alpha-arylmethylene cycloalkanones catalyzed by iridium complexes of chiral spiro aminophosphine ligands.
    Xie JB; Xie JH; Liu XY; Kong WL; Li S; Zhou QL
    J Am Chem Soc; 2010 Apr; 132(13):4538-9. PubMed ID: 20232874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INDOLPhos: novel hybrid phosphine-phosphoramidite ligands for asymmetric hydrogenation and hydroformylation.
    Wassenaar J; Reek JN
    Dalton Trans; 2007 Sep; (34):3750-3. PubMed ID: 17712439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1-symmetric carbohydrate diphosphite ligands for asymmetric Pd-allylic alkylation reactions. Study of the key Pd-allyl intermediates.
    Gual A; Castillón S; Pàmies O; Diéguez M; Claver C
    Dalton Trans; 2011 Mar; 40(12):2852-60. PubMed ID: 21305094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly enantioselective synthesis of alpha-hydroxy phosphonic acid derivatives by Rh-catalyzed asymmetric hydrogenation with phosphine-phosphoramidite ligands.
    Wang DY; Hu XP; Huang JD; Deng J; Yu SB; Duan ZC; Xu XF; Zheng Z
    Angew Chem Int Ed Engl; 2007; 46(41):7810-3. PubMed ID: 17847138
    [No Abstract]   [Full Text] [Related]  

  • 37. Highly enantioselective asymmetric hydrogenation of beta-acetamido dehydroamino acid derivatives using a three-hindered quadrant rhodium catalyst.
    Wu HP; Hoge G
    Org Lett; 2004 Sep; 6(20):3645-7. PubMed ID: 15387569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand self-sorting and nonlinear effects in dinuclear asymmetric hydrogenation: complexity in catalysis.
    Terrade FG; Lutz M; Reek JN
    Chemistry; 2013 Aug; 19(32):10458-62. PubMed ID: 23843369
    [No Abstract]   [Full Text] [Related]  

  • 39. Chiral allene-containing phosphines in asymmetric catalysis.
    Cai F; Pu X; Qi X; Lynch V; Radha A; Ready JM
    J Am Chem Soc; 2011 Nov; 133(45):18066-9. PubMed ID: 21972824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of phosphine containing amino acids: utilization of peptide synthesis in ligand design.
    Agarkov A; Greenfield S; Xie D; Pawlick R; Starkey G; Gilbertson SR
    Biopolymers; 2006; 84(1):48-73. PubMed ID: 16235230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.